Research Article
Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS
Table 1
Effects of TGF-β1 on the viability of HSC-LX2 cells (mean ± SD, n = 3).
| Group | Dose (ng·mL−1) | 24 h | 48 h | 72 h | OD | Viability (%) | OD | Viability (%) | OD | Viability (%) |
| Solvent control | — | 0.183 ± 0.004 | — | 0.175 ± 0.004 | — | 0.210 ± 0.001 | — |
| Blank control | — | 0.395 ± 0.102 | — | 0.671 ± 0.023 | — | 1.739 ± 0.197 | — |
| TGF-β1 | 5 | 0.347 ± 0.054 | 77.35 ± 0.75 | 0.711 ± 0.072 | 108.11 ± 3.26 | 0.573 ± 0.109# | 23.76 ± 2.65 | 10 | 0.501 ± 0.028 | 150.72 ± 0.62 | 0.775 ± 0.042 | 121.10 ± 2.61 | 0.596 ± 0.035# | 25.24 ± 2.41 | 20 | 0.511 ± 0.067 | 154.71 ± 0.86 | 0.820 ± 0.103 | 130.12 ± 4.51 | 1.316 ± 0.136 | 47.63 ± 1.04 | 40 | 0.695 ± 0.105# | 215.52 ± 1.96 | 0.894 ± 0.110 | 145.21 ± 5.62 | 1.311 ± 0.185 | 72.13 ± 3.65 | 80 | 0.640 ± 0.108# | 241.49 ± 0.21 | 1.093 ± 0.079# | 177.59 ± 2.54 | 2.472 ± 0.145# | 148.51 ± 2.54 | 100 | 0.803 ± 0.101# | 292.45 ± 0.26 | 1.755 ± 0.081## | 318.39 ± 6.26 | 2.728 ± 0.177# | 164.54 ± 3.22 |
|
|
Compared with the blank control group ( , ). |